Stay updated on Cabozantinib for Merkel Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page
- Check6 days agoChange DetectedThe revision label on the page changed from v3.6.4 to v3.6.5, signaling a small deployment or patch rather than content updates.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page revision updated from v3.6.3 to v3.6.4, indicating a minor update to the page version. There are no changes to the study content or results.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedThe revision label on the page was updated from v3.6.2 to v3.6.3, indicating a new build/version deployment of the page.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page’s revision label was updated from v3.6.0 to v3.6.2, indicating a minor update to the page template.SummaryDifference0.1%

- Check63 days agoChange DetectedThe study record now indicates that enrollment has ended ('No longer looking for participants') and adds new help/navigation sections: 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. It also shows a UI text formatting change for 'Intervention/Treatment' and updates the revision banner from v3.5.5 to v3.6.0.SummaryDifference0.6%

- Check70 days agoChange DetectedThe page footer revision label updated from v3.5.4 to v3.5.5, indicating a newer site revision.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib for Merkel Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page.